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Background/aim: Diabetic foot ulcers and related complications are a major cause of morbidity and hospital admissions. Our aim was
to evaluate the risk factors associated with poor outcome in diabetic foot ulcers.
Materials and methods: A prospective study was conducted on patients with diabetic foot ulceration attending the Madinah Teaching
Hospital from June 2014 to December 2015. Potential risk factors and laboratory test results at presentation were recorded and their
association with outcome (healing vs. amputation) was analyzed using IBM SPSS Statistics for Windows, Version 22.0.
Results: In total, 112 patients were studied during our study period. The majority of the patients were male (60.7%) and aged 50 years
and older (62.5%). Regarding the outcome, 68% healed completely, 27.7% underwent amputation, and 4.5% died during this period.
Patient age of 50 and older, long duration of diabetes (>10 years), rural origin, and heel ulcers were significantly associated with poor
outcome (P < 0.05).
Conclusion: Patients with diabetes should have a detailed annual foot examination; those having risk factors for poor outcome require
more frequent foot care, patient education, and early referral to tertiary care centers.
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1. Introduction
Among people diagnosed with diabetes mellitus, the
lifetime risk of developing a foot ulcer is approximately
15%. The most feared consequence of a foot ulcer is limb
amputation, which occurs 10 to 30 times more frequently
in diabetics as compared to nondiabetics (1–3). It has been
observed that the presence of foot ulceration increases
hospitalization duration by 59% in people with diabetes
mellitus (4). Worldwide, every year more than 1 million
people lose a leg as a consequence of this disease (5).
Diabetic foot ulceration is painful, demands increased
healthcare utilization, and increases healthcare costs for
the patients as well as the healthcare system (6,7).
In diabetic foot patients complications and mortality
are closely related to the severity of the disease at
presentation. Once an ulcer has developed, there is an
increased risk of wound progression ultimately leading to
amputation, suggesting that prevention and appropriate
management of foot lesions are of paramount importance
(8,9). The literature shows several risk factors related to
poor outcome in diabetic foot ulcer patients, such as poor
glycemic control, peripheral neuropathy, ischemia from
peripheral arterial disease, structural foot deformity, and
concomitant infection (10,11).
* Correspondence: dsairaijaz32@yahoo.com
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Generally, management of foot ulceration should
address glycemic control, pressure relief/offloading,
infection control, revascularization when necessary, and
local wound care (12). Management is best achieved with
a multidisciplinary team approach (13,14). At least 40%
of amputations in diabetic patients can be prevented with
a team approach to wound care (15). The incidence of
diabetic foot ulceration is higher in developing countries
like Pakistan because of various sociocultural factors (16).
In this study, we evaluated the risk factors related to poor
outcome in diabetic patients with foot ulcers.
2. Materials and methods
A prospective study was conducted with diabetic patients
with foot ulcers attending the Madinah Teaching Hospital
in Faisalabad from June 2014 to December 2015. Patients
lost in follow-up and moribund patients were excluded.
Patient age, sex, rural/urban origin, type and duration
of diabetes, history of hypertension, duration of ulcer,
previous history of ulceration, previous treatment, and
site of ulcer were recorded on the first visit. Important
laboratory tests like complete blood count, fasting/
random blood sugar, HbA1c, blood urea, creatinine, and
lipid profile were advised at the first visit.
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Clinical signs of infection, ischemia, and neuropathy
were recorded at presentation. Ulcers were labeled as
infected if a purulent discharge was present with two
other local signs (warmth, erythema, lymphangitis,
lymphadenopathy, edema, pain). Wound depth was
evaluated using a sterile blunt probe. The ability to probe
to bone along with the presence of local or systemic
infection and suggestive radiological features provided a
clinical diagnosis of osteomyelitis (17).
Each patient underwent an assessment of the vascular
status by manual palpation of femoral, popliteal, dorsalis
pedis, and posterior tibial arteries to define patency and
grade: a) good volume, b) diminished volume, or c) absent.
Patients having clinical signs of ischemia had noninvasive
ultrasound (Doppler) vascular studies (18).
Loss of protective sensation (neuropathy) was assessed
with a 128-Hz tuning fork for vibration sense and a 10-g
monofilament for perception of pressure sense. The
monofilament was applied perpendicularly to the plantar
surface of the first toe; the first, third, and fifth metatarsal
heads; and the plantar surface of the heel and the dorsum
of the foot, avoiding any callus, corn, or wound site. It was
graded as normal, reduced, or absent sensation (19).
Some patients were managed on an outpatient
department (OPD) basis while those having severe local or
systemic infection along with tissue necrosis were admitted
to the surgical ward. Wound debridement was done to
drain the pus and remove necrotic tissue and extensive
callus. Broad spectrum antibiotics were advised in the
presence of infection. After discharge from the hospital,
patients were initially seen in the OPD on a weekly basis,
and later as the healing started on a monthly basis.
Outcomes were recorded as complete healing or lower
extremity amputation (LEA). LEA is defined as major
amputation if there is loss of any part of the lower limb
above the ankle and as minor if below this joint (20).
2.1. Statistical analysis
Frequency distributions and percentages were calculated
for all the qualitative variables used in the study. The chisquare test was employed to assess the significance of
association between the risk factors and outcomes of foot
ulcers (amputation/healing without amputation).
If a potential risk factor was dichotomous and the
frequency of one of the cells was less than five, Fisher’s
exact test was used instead of the chi-square test. Odds
ratios were calculated in simple binary logistic regression
analysis for every potential risk factor.
Variables that were statistically significant risk factors
for amputation were later used in multiple binary logistic
regression analysis in order to calculate adjusted odds
ratios. The 95% confidence interval (CI) was calculated
wherever found appropriate. P-values of less than 0.05
were considered significant with two-tailed tests. Statistical

analysis was performed using IBM SPSS Statistics for
Windows, Version 22.0 (IBM Corp., 2013) (21). The results
were expressed through frequencies, tables, and graphs.
3. Results
The study population consisted of 112 patients. The
majority of the patients were male (60.7%) and aged 50
years and older (62.5%), with a mean age of 54.5 ± 10.2
years. Average follow-up time was 4.3 months (range: 2
weeks to 8 months).
Regarding outcome, 76 patients (68%) healed
completely, without amputation. Thirty-one patients
(27.7%) underwent amputation and five patients (4.5%)
died during our study period. Four patients died due to
cardiovascular events and one due to septicemia and
multiorgan failure.
Potential risk factors and their association with
outcome (healing vs. amputation) are shown in Table
1. Age of 50 and older, longer duration of diabetes (>10
years), and rural origin were significantly associated with
poor outcome at P = 0.001, P < 0.001, and P = 0.047,
respectively. These factors associated with poor outcome
were subjected to multiple binary logistic regression
analysis in order to calculate adjusted odds ratios. This
showed a strong association of poor outcome with age and
rural origin, as shown in Table 2.
Regarding types of amputation, our study showed
that 17 patients had minor and 14 patients had major
amputations. Because of the smaller number of patients
with major amputations in the dorsum of the foot
and included in the metatarsal heads group, they were
reclassified into the toes ulcer group and a comparison
was done with heel ulcers to find an association with major
amputations. The chi-square test showed that heel ulcer
is significantly associated with major amputation (P <
0.034), and according to the odds ratio, patients with heel
ulcer have a 3.609 times higher chance of having a major
amputation than patients with ulcers on the toes and
other sites, as shown in Table 3. Sixty patients had ulcers
located on the toes, accounting for 58% of all amputations;
however, the majority of amputations in patients with toe
ulcers were minor, as shown in the Figure.
Regarding types of ulcers, neuropathic ulcers were the
most common type (46.4%), followed by neuroischemic
(35.7%) and ischemic (17.9%). No statistically significant
association was found between poor outcome and type of
ulcer.
4. Discussion
Foot ulcers are a major cause of morbidity and
hospitalization in patients with diabetes. The economic
burden associated with diabetic foot ulceration is
enormous. The estimated cost of treating one foot ulcer
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Table 1, Association of potential risk factors and outcome in diabetic foot ulcer patients.
Outcome* n = 107
Factors related to foot ulcers
n = 112

Univariate analysis

Patients without
amputation
n = 76 (67.9%)

Patients with
amputation
n = 31 (27.7%)

Odds ratio
(95% CI)

P-value

38 (35.5%)
38 (35.5%)

4 (3.7%)
27 (25.2%)

6.750
(2.154–21.154)

0.001

33 (30.8%)
43 (40.2%)

10 (9.3%)
21 (19.6%)

1.612
(0.669– 3.882)

0.287

66 (61.7%)
10 (9.3%)

11 (10.3%)
20 (18.7%)

12.000
(4.451–32.353)

<0.001

0.875
(0.325– 2.353)

0.791

Age (in years)
<50 years: 42 (37.5%)
>50 years: 70 (62.5%)
Sex
Female: 44 (39.3%)
Male: 68 (60.7%)
Area
Rural: 78 (69.6%)
Urban: 34 (30.4%)
Previous H/O foot ulcer
Yes: 85 (75.9%)
No: 27 (24.1%)

57 (53.3%)
19 (17.8%)

Duration of diabetes
<10 years: 40 (35.7%)
>10 years: 72 (64.3%)

24 (22.4%)
7 (6.5%)

33 (30.8%)
43 (40.2%)

7 (6.5%)
24 (22.4%)

2.631
(1.011–6.847)

0.047

20 (18.7%)
56 (52.3%)

7 (6.5%)
24 (22.4%)

1.224
(0.457–3.278)

0.687

24 (22.4%)
52 (48.6%)

7 (6.5%)
24 (22.4%)

1.582
(0.599–4.178)

0.354

29 (27.1%)
47 (43.9%)

12 (11.2%)
19 (17.8%)

0.977
(0.414–2.305)

0.958

57 (53.3%)
19 (17.8%)

18 (16.8%)
13 (12.1%)

2.167
(0.897–5.236)

0.086

11 (10.3%)
36 (33.6%)
29 (27.1%)

7 (6.5%)
14 (13.0%)
10 (9.4%)

0.488 (0.146–1.631)
0.745 (0.285–1.946)

0.244
0.548

Type of DM
Type 1: 30 (26.8%)
Type 2: 82 (73.2%)
HbA1c
<7.5: 31 (27.7%)
>7.5: 81 (72.3%)
Hypertension
No: 42 (37.5%)
Yes: 70 (62.5%)
LDL cholesterol
< 130 mg/dL: 79 (70.5%)
> 130 mg/dL: 33 (29.5%)
Type of ulcer
Ischemic: 20 (17.9%)
Neuropathic: 52 (46.4%)
Neuroischemic: 40 (35.7%)

*Deceased patients (n = 5) are included in the total number of patients (n = 112), but are not mentioned for outcome
(n = 107).

828

SALEEM et al. / Turk J Med Sci
Table 2. Multivariate analysis.
Factors

Adjusted odds ratio

95% CI

P-value

6.910 (1.519–31.432)

0.012

0.012

0.810 (0.194–3.381)

0.773

0.773

11.215 (3.878–32.430)

<0.001

<0.001

Age
<50 years
>50 years
Duration of diabetes
<10 years
>10 years
Rural origin
No
Yes

Table 3. Association between site of foot ulcer and major amputations.
Site of foot ulcer (n* = 107)

Major amputations n = 14

Heel

22

6

Toes and other sites

85

8

CI (95%)

P-value

3.609 (1.101–11.836)

0.034

*Excluding deceased patients.

60

60

50
40
13

30
20
10

3
5

15

2

1
10

1

0

Site of ulcer distribution n=107

22

6

0

Minor Amputations n=17
Site of ulcer distribution n=107

Major Amputation n=14

Minor Amputations n=17

Figure. Ulcer site distribution and its association with type of amputation.

over a 2-year period is $28,000 (9). The prevalence of
lower extremity amputation is high in Pakistan, but the
underlying risk factors remain to be defined (18). In this
study, we assessed various clinical and biochemical factors
leading to poor outcome in patients with diabetic foot
ulceration. Early detection and proper care of a foot at risk
can help prevent complications like amputation.

Our study shows that the majority of patients were
male and over 50 years old. Other researchers have also
reported the presence of diabetic ulcers mostly in males
and middle-aged subjects (22–24). The increase in foot
ulcers among diabetic male patients is worrying for
individual families, as males are often the sole earning
member of the family (22).
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In our study 76 patients (68%) healed completely
without amputation, while 31 patients (27.7%) underwent
lower limb amputation. Similar results were shown by Ali
et al. from Karachi (18).
Australian recommendations on the prevention,
identification, and management of foot complications
in diabetes classify half of lower limb amputations as
major (below or above knee) and the other half as minor
(distal to the ankle) (25). Our study shows that nearly
half of the amputations were major, and 43% of these
major amputations occurred for heel ulcers as compared
to 35.7%, 14.3%, and 7% for toes, under metatarsal
heads, and the dorsum of foot ulcers, respectively.
Younes et al. from Jordan also reported heel ulcers to
be the most serious of foot ulcers and associated with
major amputations. Management of heel ulcers requires
a thorough knowledge of risk factors for ulceration in
the heel area and a standardized program of ulcer care.
Patient education regarding foot hygiene, skin care, and
proper footwear can reduce the risk of injury that can lead
to heel ulceration. Team management programs using
careful foot examination and proper therapeutic measures
can significantly reduce the risk of lower-extremity
amputations due to heel ulcers (26).
Regarding patient residence, 69.6% of patients came
from rural areas, which was significantly associated with
poor outcome. This is probably related to poor access to
healthcare facilities in rural communities. Similarly, Shahi
et al. from India reported that 70.1% of patients were from
rural areas, which was associated with poor outcome.

As described in this Indian study, people living in rural
areas often sleep in farm houses, huts, or outdoors in the
villages and they walk bare-footed and commonly get foot
damage and chronic ulcers (22). An Australian study also
reported diabetes-related foot complications to be more
common in Aboriginal and Torres Strait Islanders living in
remote areas as compared to those living in central areas.
The authors concluded that these populations experience
barriers to access or utilization of contemporary diabetes
education and require more attention in regards to
screening, early intervention, and monitoring to improve
clinical outcomes (25).
Regarding types of ulcers, neuropathic ulcers were the
most common type (46.4%), followed by neuroischemic
(35.7%) and ischemic (17.9%); other studies showed
similar findings (10,27). However, in our study no
significant association was found between poor outcome
and type of ulcer.
We conclude that in people with diabetes foot
examination by healthcare providers should be an integral
component of diabetes management to identify patients
at risk of ulceration and lower-extremity amputation, and
this should be performed at least annually. Patients at high
risk of foot complications need more frequent monitoring
as well as foot care education (including counseling to
avoid foot trauma), professionally fitted footwear, and early
referrals to a tertiary care center with trained professionals
in foot ulcer management. A multidisciplinary healthcare
team can help prevent recurrent foot ulcers and amputation
in these patients (28).
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